If You Invested $1000 In Alnylam Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 12.41% on an annualized basis producing an average annual return of 25.61%. Currently, Alnylam Pharmaceuticals has a market
Alnylam stock grew much faster than the overall market over 15 years. When a company has a long track record of strong growth, it shows investors believe in its future plans.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.